Cardiovascular Tissue Engineering stands at the forefront of innovative approaches to address the challenges posed by cardiovascular diseases. This interdisciplinary field combines principles from biology, engineering, and materials science to develop artificial cardiovascular tissues or enhance the regenerative capacity of existing tissues. Researchers utilize biomaterials, including scaffolds and hydrogels, combined with cells and signaling molecules to create constructs that mimic the structure and function of native cardiovascular tissues. The goal is to generate functional blood vessels, heart valves, and even entire organs for transplantation. Techniques such as 3D bioprinting enable precise deposition of cells and biomaterials, facilitating the creation of complex tissue structures. Cardiovascular tissue engineering holds significant promise for personalized medicine, offering tailored solutions for patients with congenital heart defects, heart failure, or vascular disorders. While challenges like achieving optimal vascularization and integration persist, ongoing advancements in stem cell research, biomaterial development, and tissue fabrication techniques propel the field toward transformative breakthroughs in cardiovascular healthcare. The convergence of engineering and biology in cardiovascular tissue engineering represents a paradigm shift in the quest for effective and sustainable solutions to combat cardiovascular diseases.
Title : AI-integrated high-throughput tissue-chip for space-based biomanufacturing applications
Kunal Mitra, Florida Tech, United States
Title : Stem cell technologies to integrate biodesign related tissue engineering within the frame of cell based regenerative medicine: towards the preventive therapeutic and rehabilitative resources and benefits
Sergey Suchkov, N.D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences, Russian Federation
Title : In vitro evaluation of lyophilized Dedifferentiated Fat cells (DFAT) impregnated artificial dermis
Kazutaka Soejima, Nihon University, School of Medicine, Japan
Title :
Nagy Habib, Imperial College London, United Kingdom
Title :
Alexander Seifalian, Nanotechnology & Regenerative Medicine Commercialisation Centre, United Kingdom
Title : The regenerative medicine of the future
Marco Polettini, DVM, Italy